Ha habido 50 transacciones internas recientes registradas para Clearside Biomedical, Inc. (CLSD), incluyendo 38 compras y 9 ventas. El total de compras internas fue valorado en $4.55M y el total de ventas internas en $136.04K.
Internos destacados con actividad reciente incluyen Thorp Clay, Lasezkay George M, Deignan Charles A.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — CLSD
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-02-24 |
Thorp Clay |
Director |
Compra Informativa |
15,000 |
$0.92 |
$13.8K |
176,141 |
| 2025-01-08 |
Lasezkay George M |
CEO |
Concesión de RSU |
500,000 |
$0.97 |
$485K |
500,000 |
| 2025-01-08 |
Deignan Charles A. |
Chief Financial Officer |
Concesión de RSU |
200,000 |
$0.97 |
$194K |
200,000 |
| 2025-01-08 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Concesión de RSU |
250,000 |
$0.97 |
$242.5K |
250,000 |
| 2024-11-01 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Compra Informativa |
36,500 |
$1.00 |
$36.5K |
100,000 |
| 2024-06-24 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Compra Informativa |
23,500 |
$1.06 |
$24.91K |
63,500 |
| 2024-06-20 |
Yerxa Benjamin R |
Director |
Concesión de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Shaffer Christy L |
Director |
Concesión de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Edwards Jeffrey L |
Director |
Concesión de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Hutson Nancy J |
Director |
Concesión de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Thorp Clay |
Director |
Concesión de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Croarkin Richard |
Director |
Concesión de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Humphries William D. |
Director |
Concesión de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Gibney Anthony S |
Director |
Concesión de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-05-15 |
Yerxa Benjamin R |
Director |
Compra Informativa |
7,813 |
$1.31 |
$10.24K |
17,957 |
| 2024-04-18 |
Gibney Anthony S |
Director |
Compra Informativa |
93,290 |
$1.30 |
$121.28K |
100,000 |
| 2024-04-17 |
Gibney Anthony S |
Director |
Compra Informativa |
6,710 |
$1.25 |
$8.39K |
6,710 |
| 2024-04-15 |
Gibney Anthony S |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-04-15 |
Gibney Anthony S |
Director |
Concesión de RSU |
45,000 |
$1.29 |
$58.05K |
45,000 |
| 2024-03-20 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Compra Informativa |
30,000 |
$1.60 |
$48K |
30,000 |
| 2024-03-18 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Concesión de RSU |
450,000 |
$1.56 |
$702K |
450,000 |
| 2024-03-14 |
Chong Ngai Hang Victor |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-03-14 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Disposición |
- |
- |
- |
10,000 |
| 2024-02-07 |
Whitmore Bradford T |
10 Percent Owner |
Compra Informativa |
444,444 |
$1.62 |
$720K |
444,444 |
| 2024-01-19 |
Lasezkay George M |
CEO |
Venta Informativa |
18,000 |
$1.27 |
$22.86K |
466,577 |
| 2024-01-19 |
Deignan Charles A. |
Chief Financial Officer |
Venta Informativa |
12,900 |
$1.28 |
$16.51K |
384,662 |
| 2024-01-18 |
Lasezkay George M |
CEO |
Concesión de RSU |
439,500 |
$1.29 |
$566.96K |
439,500 |
| 2024-01-18 |
Deignan Charles A. |
Chief Financial Officer |
Concesión de RSU |
200,000 |
$1.29 |
$258K |
200,000 |
| 2023-11-01 |
Whitmore Bradford T |
10 Percent Owner |
Compra Informativa |
64,366 |
$0.74 |
$47.9K |
4,050,590 |
| 2023-10-31 |
Whitmore Bradford T |
10 Percent Owner |
Compra Informativa |
70,812 |
$0.73 |
$51.54K |
3,986,224 |
| 2023-10-30 |
Whitmore Bradford T |
10 Percent Owner |
Compra Informativa |
600 |
$0.69 |
$411.00 |
3,915,412 |
| 2023-10-27 |
Whitmore Bradford T |
10 Percent Owner |
Desconocido |
- |
- |
- |
2,350,152 |
| 2023-10-03 |
Hutson Nancy J |
Director |
Compra Informativa |
10,000 |
$0.86 |
$8.6K |
93,000 |
| 2023-09-25 |
Thorp Clay |
Director |
Compra Informativa |
10,000 |
$0.86 |
$8.6K |
40,522 |
| 2023-09-22 |
Humphries William D. |
Director |
Ejercicio de Opciones (Venta) |
22,727 |
$0.40 |
$9.09K |
- |
| 2023-09-18 |
Lasezkay George M |
CEO |
Concesión de RSU |
200,000 |
$0.85 |
$169.8K |
200,000 |
| 2023-09-18 |
Deignan Charles A. |
Chief Financial Officer |
Concesión de RSU |
100,000 |
$0.85 |
$84.9K |
100,000 |
| 2023-09-13 |
Deignan Charles A. |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
34,090 |
$0.40 |
$13.64K |
- |
| 2023-06-22 |
Yerxa Benjamin R |
Director |
Concesión de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Shaffer Christy L |
Director |
Concesión de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Edwards Jeffrey L |
Director |
Concesión de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Hutson Nancy J |
Director |
Concesión de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Thorp Clay |
Director |
Concesión de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Croarkin Richard |
Director |
Concesión de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Humphries William D. |
Director |
Concesión de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-01-20 |
Ciulla Thomas |
Chief Medical Officer |
Venta Informativa |
13,700 |
$1.47 |
$20.14K |
291,890 |
| 2023-01-19 |
Lasezkay George M |
CEO |
Venta Informativa |
20,030 |
$1.46 |
$29.24K |
484,577 |
| 2023-01-19 |
Deignan Charles A. |
Chief Financial Officer |
Venta Informativa |
14,030 |
$1.50 |
$21.05K |
363,472 |
| 2023-01-10 |
Ciulla Thomas |
Chief Medical Officer |
Venta Informativa |
2,170 |
$1.62 |
$3.52K |
305,590 |
| 2023-01-04 |
Lasezkay George M |
CEO |
Concesión de RSU |
487,500 |
- |
- |
487,500 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
